Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2010
03/18/2010WO2010030687A1 Monoclonal antibodies specific for pancreatic neoplasia cells
03/18/2010WO2010030686A1 Multi-stage, regression-based pcr analysis system
03/18/2010WO2010030655A1 Cell culture system for determining the sensitizing, allergenic and/or irritating effect of a substance
03/18/2010WO2010030641A2 Pancreatic cancer markers
03/18/2010WO2010030624A1 Methods for diagnosis and assessment of autoimmune disorders
03/18/2010WO2010030608A1 Methods for detecting and quantifying oversulfated glycosaminoglycans
03/18/2010WO2010030604A2 Methods and compositions for determining and monitoring dietary supplementation
03/18/2010WO2010030425A1 Open-reading-frame (orf) phage display
03/18/2010WO2010030393A1 Methods for quantifying protein leakage from protein based affinity chromatography resins
03/18/2010WO2010030355A2 Targeted chemical high-throughput screening method
03/18/2010WO2010030354A1 Base oil low temperature property classification model
03/18/2010WO2010030243A1 Gene sequences for the detection of chikungunya and dengue fever
03/18/2010WO2010030203A1 Monoclonal antibody to human amyloidogenic and modified forms of transthyretin and its use in the detection and treatment of fap and pathologies presenting modified ttr
03/18/2010WO2010030189A1 Fluid analysis system and method for operation of an analysis system
03/18/2010WO2010030162A2 Improved capacitive sensor and method for making the same
03/18/2010WO2010029739A1 Polymer particles containing fluorescent molecule and process for producing same
03/18/2010WO2010029504A1 Kit useful for detecting, separating and/or characterizing a molecule of interest
03/18/2010WO2010029498A1 Improved wire grid substrate structure and method for manufacturing such a substrate
03/18/2010WO2010029440A1 Molecular classifier for evaluating the risk of metastasic relapse in breast cancer
03/18/2010WO2010029390A1 A spectrometric device
03/18/2010WO2010029360A1 Compositions and methods for the rapid growth and detection of microorganisms
03/18/2010WO2010029312A1 Carbohydrate binding molecules
03/18/2010WO2010029175A1 Detection method and device based on nanoparticle aggregation
03/18/2010WO2010029165A1 Method and device for the detection of anions
03/18/2010WO2010029164A1 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence
03/18/2010WO2010029118A1 Method for identifying compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
03/18/2010WO2010029116A1 Natriuretic peptides and adiponectin in subjects with a metabolic syndrome
03/18/2010WO2010029115A1 Methods useful in studying or modulating skin or hair pigmentation, plant extracts for use in compositions and cosmetic care method
03/18/2010WO2010029018A1 Method and apparatus for determining the ethanol proportion of the fuel in a motor vehicle
03/18/2010WO2010028889A1 Determination of equilibrium constants in solution by means of multi-step kinetics
03/18/2010WO2010028658A1 Ykl-40 as a marker for gastrointestinal cancers
03/18/2010WO2010028657A1 Ykl-40 as a marker for selection of treatment and monitoring of a disease
03/18/2010WO2010028656A1 Methods for classifying the severity of diseases or disorders
03/18/2010WO2010028651A2 Method of upregulating sorla for the treatment of alzheimer's disease
03/18/2010WO2010028646A1 Prostate cancer biomarker
03/18/2010WO2010028642A1 Contactless method for controlling the thickness of a preparation layer applied to a yarn and circuit arrangement for carrying out said method
03/18/2010WO2010028487A1 Bidesmosidic betulin and betulinic acid derivatives and uses thereof as antitumor agents
03/18/2010WO2010011775A3 Detection and quantification of antigens
03/18/2010WO2010011583A3 Method for classifying and counting bacteria in body fluids
03/18/2010WO2010011438A3 Optimizing selection of srm transitions for analysis of biomolecules by tandem mass spectrometry
03/18/2010WO2010010547A3 Semiconductor detector for peroxide-based explosives
03/18/2010WO2010010469A3 Amyloid beta (x - 38.. 43) oligomers, and processes, compositions, and uses thereof
03/18/2010WO2010006588A3 Method and device for analysing biogas
03/18/2010WO2010004136A3 Triaxial cell for the testing of geomaterials in compression and in shear
03/18/2010WO2010000493A3 Inorganic-binding peptides and quality control methods using them
03/18/2010WO2009156178A8 Flow-cytometric method for the determination of the total leukocyte number and thrombocyte number and for the leukocyte differentiation in avian blood samples
03/18/2010WO2009155331A4 System, program product and related methods for estimating and managing crude gravity in real-time
03/18/2010WO2009154375A3 Method for identifying blood-derived glycoprotein using specific lectin affinity chromatography
03/18/2010WO2009153136A3 Means and methods for assessing liver toxicity
03/18/2010WO2009148528A8 Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
03/18/2010WO2009146098A3 Stem cells and uses thereof
03/18/2010WO2009143519A3 Biomarkers for myocardial ischemia
03/18/2010WO2009140039A3 Synthetic antibodies
03/18/2010WO2009139889A4 Apparatus and method for optically sensing analyte concentration in an erythrocyte-containing fluid
03/18/2010WO2009138689A3 In vitro detection of antibodies produced following a legionella pneumophila infection
03/18/2010WO2009137091A3 Catestatin (cst) and its variants for treatment of cardiovascular and metabolic disorders
03/18/2010WO2009132209A3 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
03/18/2010WO2009128009A9 Flow-through biosensor
03/18/2010WO2009126804A3 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis
03/18/2010WO2009121024A3 Methods for detecting antibodies
03/18/2010WO2009111073A3 High-content and high throughput assays for identification of lipid-regulating pathways, and novel therapeutic agents for lipid disorders
03/18/2010WO2005042711A9 Pain-associated gene pnpg1
03/18/2010US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
03/18/2010US20100071078 Rspondins as modulators of angiogenesis and vasculogenesis
03/18/2010US20100070202 Base oil low temperature property classification model
03/18/2010US20100070201 Method and apparatus for measuring multiple parameters in-situ of a sample collected from environmental systems
03/18/2010US20100070196 Blood Glucose Tracking Apparatus and Methods
03/18/2010US20100070194 Methods for rapid identification and quantitation of nucleic acid variants
03/18/2010US20100070192 Optimization of crossover points for directed evolution
03/18/2010US20100070191 Lung Cancer Biomarkers and Uses Thereof
03/18/2010US20100069815 Substrate for biological fluid treatment
03/18/2010US20100069610 Substrates useful for fret protease assays for botulinum serotype a/e txoins
03/18/2010US20100069502 Assay
03/18/2010US20100069470 Identification of protein biomarkers associated with lymph node metastasis in colorectal cancer
03/18/2010US20100069463 Methods for the diagnosis and treatment of affective disorders and cushing's syndromes
03/18/2010US20100069322 Inhibition of cholera toxins by galatooligosaccharides (gos)
03/18/2010US20100069304 Protective effects of inhibiting the interaction of calmodulin and mutant huntingtin protein
03/18/2010US20100069300 C-Type Lectin Fold as a Scaffold for Massive Sequence Variation
03/18/2010US20100069299 Ghrelin analogs
03/18/2010US20100069298 Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
03/18/2010US20100069259 Sample device preservation
03/18/2010US20100069252 Efficient method for partial sequencing of peptide/protein using acid or base labile xanthates
03/18/2010US20100068827 Stabilized Standards for Busulfan Immunoassay
03/18/2010US20100068826 Hybrid phase lateral flow assay
03/18/2010US20100068825 Method and Device for Detecting at Least One Property of at Least One Object with a Microchip
03/18/2010US20100068824 Sensing method, sensing device, inspection chip, and inspection kit
03/18/2010US20100068823 Carrier Material, Method for the Production and Use Thereof
03/18/2010US20100068821 Method for detection and analysis of aromatic hydrocarbons from water
03/18/2010US20100068820 Molecularly imprinted polymer and use thereof in diagnostic devices
03/18/2010US20100068819 Compounds and methods for double labelling of polypeptides to allow multiplexing in mass spectrometric analysis
03/18/2010US20100068818 Algorithms for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer
03/18/2010US20100068817 Colorimetric detection of metallic ions in aqueous media using functionalized nanoparticles
03/18/2010US20100068803 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
03/18/2010US20100068798 Intelligent multifunctional medical device apparatus and components
03/18/2010US20100068797 Method for the visual detection of specific antibodies by the use of lateral flow assays
03/18/2010US20100068796 Blood Glucose Tracking Apparatus and Methods
03/18/2010US20100068749 Optical sensor and method for indicating the age or quality of a natural product
03/18/2010US20100068738 Method of Immunoassaying A Component to be Measured
03/18/2010US20100068737 Enzyme-linked Immunosorbent Assay (ELISA) for Canine Hepcidin
03/18/2010US20100068736 Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer